查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2094163

高通量篩檢市場－2026-2032年全球市場預測

High-Throughput Screening Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，高通量篩檢市場將成長至 334.4 億美元，複合年成長率為 5.94%。

主要市場統計數據
基準年 2025 223.2億美元
預計年份：2026年 232.4億美元
預測年份 2032 334.4億美元
複合年成長率 (%) 5.94%

高通量篩檢(HTS) 已成為現代藥物發現、化學生物學、毒理學、基因組學和精準醫學的核心技術。 HTS 結合了自動化液體處理、基於微孔盤的檢測、機器人技術、微型化工作流程、高內涵成像和先進的數據分析，使研究人員能夠快速、可重複且統計學嚴謹地評估大規模的小分子、生物製劑、基因敲除和細胞模型庫。其價值與快速識別先導化合物、提高檢測品質、減少試劑消耗以及更順暢地從早期藥物發現過渡到下游檢驗的需求日益密切相關。

該領域正從以數量為導向的篩檢朝向以洞察主導的實驗發展。實驗室優先考慮生理相關的細胞分析、類器官、3D培養方法、表現型篩檢、無標定檢測以及能夠建構更深層生物學背景的多重分析結果。同時，隨著高通量篩選（HTS）與轉化研究和臨床決策流程的整合日益緊密，對可靠的分析檢驗、資料完整性、符合監管要求的文檔以及可互通的資訊系統的需求也日益成長。

高通量篩檢領域的變革性變化

高通量篩檢領域正因自動化、檢測微型化以及生物學資訊豐富的測量結果的整合而重塑。儘管傳統的生化檢測在基於靶點的篩檢中仍然至關重要，但隨著研究人員尋求能夠更好地反映疾病生物學本質的訊號，基於細胞和表現型的方法正日益受到關注。高內涵篩檢拓展了顯微鏡和影像分析的應用範圍，使實驗室能夠在單一工作流程中捕捉形態、細胞內分佈形態、細胞毒性、訊號路徑調控以及多參數細胞反應等資訊。

人工智慧對高通量篩選的累積影響。

人工智慧正透過改善實驗設計、影像解讀、化合物優先排序、異常檢測和決策，對整個高通量篩選（HTS）工作流程產生累積影響。機器學習模型正被擴大用於分析高維度篩檢資料集、識別細微的表現型模式、減少假陽性結果，並將檢測結果與化學結構、體學特徵和已知的生物路徑關聯起來。在高內涵篩檢中，電腦視覺和深度學習正在支援自動分割、特徵提取和表現型分類，從而減少人工審核並提高結果的一致性。

高通量篩檢應用的關鍵區域見解。

在亞太地區，不斷擴展的生物醫學研究基礎設施、對生物技術的大力投資以及基因組學、細胞生物學和自動化實驗室操作能力的提升，為高通量篩檢提供了有力支撐。中國、日本、韓國、印度、新加坡和澳洲正共同建構一個快速發展的區域生態系統，並日益重視轉化研究、生技藥品發現、感染疾病研究和精準醫療。該地區在產學研合作和數位化實驗室現代化方面的優勢，正推動高內涵成像、化合物篩檢、自動化液體處理和人工智慧驅動的檢測分析等技術的應用。

關鍵群體見解塑造了高通量篩檢的優先事項

東協正透過新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國生命科學研究能力的提升，增強其在高通量篩檢領域的影響力。該地區的優勢包括合作臨床研究、感染疾病的專業知識以及政府主導的生物技術計劃，但各國獲取先進自動化技術和專業篩檢人員的能力存在差異。海灣合作理事會（GCC）成員國正透過醫療改革、基因組研究計畫和科學研究基礎設施投資，建構更強大的高通量篩檢（HTS）能力，特別關注精準醫療、罕見疾病研究、公共衛生和轉化生物醫學平台。

來自主要國家關於高通量篩檢的見解

美國在推動高通量篩檢工作流程方面處於世界領先地位，這得益於其先進的藥物研發能力、生物技術叢集、大​​學附屬醫療中心、先進的自動化技術以及人工智慧分析技術的廣泛應用。加拿大則憑藉其強大的學術研究、轉化醫學、幹細胞科學以及協作的生物技術生態系統做出貢獻。墨西哥正透過其臨床研究能力、接近性製造地的優勢以及學術界對生物醫學篩檢日益成長的興趣來加強自身的作用，而巴西則透過其公共研究機構、感染疾病知識、農業生物技術和生物技術開發來支持拉丁美洲的高通量篩選活動。

為高通量篩檢領域的領導者提供的實用建議

產業領導者應優先考慮兼具自動化柔軟性和卓越檢測生物學性能的高通量篩選（HTS）平台。投資應集中於模組化機器人、檢驗的液體處理系統、高內涵成像技術、微孔盤讀數儀、聲波分液系統、化合物管理以及支援端到端可追溯性的整合式資訊系統。各組織應透過利用適當的對照、Z因子和信噪比評估、可重複的實驗策略、正交驗證檢測以及早期複篩檢來改進檢測方法的開發，從而降低假陽性風險。

高通量篩檢分析的調查方法

本執行摘要採用二手資料研究途徑編寫，資料來自公開、檢驗且與產業相關的資訊來源。研究過程參考了同行評審的科學文獻、監管指南、學術篩檢中心出版物、公共衛生和生物醫學研究報告、專利和技術趨勢徵兆、會議論文集以及與檢測驗證、實驗室自動化、數據完整性和生物資訊相關的認證標準。

結論：高通量篩檢作為數據驅動的藥物發現引擎

高通量篩檢正從簡單的快速樣本檢測發展成為整合的、生物學資訊豐富的、數據驅動的發現過程。自動化、小型化、高內涵成像、表現型分析和人工智慧驅動的分析技術正在提高藥物發現、毒理學、基因組學、化學生物學和轉化醫學等領域篩檢宣傳活動的效率和可解釋性。當穩健的檢測設計、可互通的資訊科學、品質管治和跨學科專業知識匯聚一堂時，將湧現最大的機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：高通量篩檢市場：依產品類型分類

  • 消耗品
    • 實驗室設備
    • 試劑和檢測試劑盒
  • 裝置
    • 檢測系統
    • 液體處理系統
  • 服務
    • 檢測方法開發與驗證
    • 篩檢
  • 軟體
    • 化合物管理
    • 數據分析

第8章：高通量篩檢市場：依技術分類

  • 基於細胞的檢測
    • 螢光成像盤式分析儀儀檢測
    • 基於報告基因的檢測
  • 晶片實驗室技術（LOC）
  • 無標定技術
  • 基於微流體技術的

第9章：高通量篩檢市場：依板型分類

  • 1536孔盤
  • 384孔盤
  • 96孔盤

第10章：高通量篩檢市場：依應用領域分類

  • 藥物發現
  • 基因組學和蛋白​​質組學
  • 分子篩檢
  • 毒理學和安全性評估

第11章 高通量篩檢市場：依最終使用者分類

  • 學術研究機構
  • 受託研究機構
  • 醫院和診斷檢查室
  • 製藥和生物技術公司

第12章：高通量篩檢市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：高通量篩檢市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：高通量篩檢市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Agilent Technologies, Inc.
  • Aurora Biomed, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomat Srl
  • BMG LABTECH GmbH
  • BRAND GMBH+CO KG
  • Charles River Laboratories International, Inc.
  • Corning Incorporated
  • Creative Biolabs, Inc.
  • Danaher Corporation
  • DIANA Biotechnologies, as
  • Eppendorf SE
  • EUROFINS SCIENTIFIC SE
  • Gilson Company, Inc.
  • Hamilton Company
  • HighRes BioSolutions, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Mettler Toledo International, Inc.
  • PerkinElmer, Inc.
  • Revvity, Inc.
  • Sartorius AG
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Waters Corporation
Product Code: MRR-501246436FA8

The High-Throughput Screening Market is projected to grow by USD 33.44 billion at a CAGR of 5.94% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 22.32 billion
Estimated Year [2026] USD 23.24 billion
Forecast Year [2032] USD 33.44 billion
CAGR (%) 5.94%

High-throughput screening (HTS) has become a core capability in modern drug discovery, chemical biology, toxicology, genomics, and precision medicine. By combining automated liquid handling, microplate-based assays, robotics, miniaturized workflows, high-content imaging, and advanced data analytics, HTS enables researchers to evaluate large libraries of small molecules, biologics, genetic perturbations, and cellular models with speed, reproducibility, and statistical rigor. Its value is increasingly tied to the need for faster hit identification, improved assay quality, reduced reagent consumption, and better translation from early discovery to downstream validation.

The field is evolving from volume-driven screening toward intelligence-led experimentation. Laboratories are prioritizing physiologically relevant cell-based assays, organoids, 3D culture formats, phenotypic screening, label-free detection, and multiplexed readouts that generate deeper biological context. At the same time, demand for robust assay validation, data integrity, regulatory-aligned documentation, and interoperable informatics is rising as HTS becomes more closely connected to translational research and clinical decision pathways.

Transformative Shifts in the High-Throughput Screening Landscape

The high-throughput screening landscape is being reshaped by automation, assay miniaturization, and the integration of biology-rich readouts. Traditional biochemical assays remain essential for target-based screening, but cell-based and phenotypic approaches are gaining prominence as researchers seek signals that better reflect disease biology. High-content screening is expanding the role of microscopy and image analytics, allowing laboratories to capture morphology, intracellular localization, cytotoxicity, pathway modulation, and multi-parametric cellular responses in a single workflow.

Another major shift is the move toward flexible, modular laboratory automation. Instead of relying only on fixed robotic lines, research teams are adopting configurable platforms that can support assay development, compound management, plate handling, incubation, detection, and data capture across varied applications. Miniaturized plate formats and acoustic dispensing help reduce sample and reagent use, while established assay robustness metrics support reproducibility. Cloud-enabled laboratory information management, electronic lab notebooks, and FAIR data practices are also strengthening data traceability and collaboration across distributed discovery teams.

Cumulative Impact of Artificial Intelligence on High-Throughput Screening

Artificial intelligence is having a cumulative impact across the HTS workflow by improving experiment design, image interpretation, compound prioritization, anomaly detection, and decision-making. Machine learning models are increasingly used to analyze high-dimensional screening datasets, identify subtle phenotype patterns, reduce false positives, and connect assay outputs with chemical structures, omics profiles, and known biological pathways. In high-content screening, computer vision and deep learning support automated segmentation, feature extraction, and phenotype classification, reducing manual review and improving consistency.

AI is also strengthening active learning strategies in screening campaigns. Rather than testing libraries in a purely linear manner, models can recommend the next most informative compounds or genetic perturbations based on early results, helping researchers explore chemical and biological space more efficiently. Predictive toxicology, polypharmacology assessment, and structure-activity relationship analysis are benefiting from integrated AI pipelines. However, adoption depends on high-quality training data, standardized metadata, transparent model validation, and governance practices that address bias, reproducibility, cybersecurity, and auditability.

Key Regional Insights Across High-Throughput Screening Adoption

In Asia-Pacific, high-throughput screening is supported by expanding biomedical research infrastructure, strong investments in biotechnology, and growing capabilities in genomics, cell biology, and automated laboratory operations. China, Japan, South Korea, India, Singapore, and Australia contribute to a rapidly advancing regional ecosystem, with increasing emphasis on translational research, biologics discovery, infectious disease research, and precision medicine. The region's strengths in academic-industry collaboration and digital laboratory modernization are improving the adoption of high-content imaging, compound screening, automated liquid handling, and AI-enabled assay analytics.

North America remains a highly advanced region for HTS due to its concentration of pharmaceutical research, biotechnology innovation, academic medical centers, contract research capacity, and established regulatory science expertise. The United States and Canada continue to emphasize automation, scalable screening infrastructure, and data-driven discovery workflows across small-molecule, biologics, gene-editing, and phenotypic screening applications. Europe benefits from strong public research networks, harmonized quality expectations, and active biopharmaceutical innovation across Germany, the United Kingdom, France, Italy, Spain, and Nordic research hubs. European laboratories are increasingly focused on assay reproducibility, ethical data governance, advanced cellular models, and alternatives to animal testing.

Latin America is developing HTS capabilities through investments in biomedical research, infectious disease studies, agricultural biotechnology, and university-led screening programs, with Brazil and Mexico playing visible roles. The Middle East is building capacity through healthcare diversification strategies, genomics initiatives, and investment in research hospitals and life science infrastructure, particularly in Gulf economies. Africa's HTS adoption is more uneven but strategically relevant, especially for infectious disease research, neglected tropical disease programs, antimicrobial resistance studies, and regional public health priorities supported by academic and international research collaborations.

Key Group Insights Shaping High-Throughput Screening Priorities

ASEAN is gaining relevance in high-throughput screening through expanding life science research capabilities in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The region's strengths include clinical research connectivity, infectious disease expertise, and government-backed biotechnology initiatives, although access to advanced automation and specialized screening talent varies across countries. GCC economies are using healthcare transformation, genomics programs, and research infrastructure investments to build stronger HTS capabilities, with particular interest in precision medicine, rare disease research, population health, and translational biomedical platforms.

The European Union offers a mature environment for HTS through coordinated research funding, cross-border scientific collaboration, high regulatory standards, and strong emphasis on reproducible, ethically governed research. EU laboratories are increasingly integrating high-content screening, advanced cell models, and data-sharing frameworks to support drug discovery and toxicology. BRICS countries represent a diverse HTS growth landscape, combining large patient populations, expanding domestic pharmaceutical and biotechnology sectors, and rising investments in automation and biomedical research. China and India are especially important within this group due to their scale, scientific workforce, bioinformatics talent, and growing role in global drug discovery services and innovation.

G7 countries continue to influence HTS best practices through advanced pharmaceutical R&D, regulatory science leadership, academic excellence, and strong infrastructure for translational medicine. Their focus spans AI-enabled discovery, biologics, cell and gene therapy research, and high-content phenotypic platforms. NATO members overlap significantly with established North American and European research systems, where HTS capabilities are also relevant to biosecurity, antimicrobial resistance preparedness, toxicology, and medical countermeasure development, while maintaining strong expectations for data integrity, cybersecurity, and controlled research governance.

Key Country Insights in High-Throughput Screening

The United States leads in the sophistication of high-throughput screening workflows, supported by deep pharmaceutical research capabilities, biotechnology clusters, academic medical centers, advanced automation, and broad use of AI-enabled analytics. Canada contributes through strong academic research, translational medicine, stem cell science, and collaborative biotechnology ecosystems. Mexico is strengthening its role through clinical research capacity, manufacturing adjacency, and growing academic interest in biomedical screening, while Brazil supports Latin American HTS activity through public research institutions, infectious disease expertise, agricultural biotechnology, and biotechnology development.

In Europe, the United Kingdom is recognized for strong life sciences research, genomics leadership, and translational discovery platforms. Germany contributes through engineering excellence, pharmaceutical R&D, automation expertise, and rigorous quality systems. France supports HTS through biomedical institutes, oncology research, immunology, and public-private research networks. Russia maintains capabilities in chemical biology, virology, and academic research, though collaboration patterns are influenced by geopolitical and regulatory constraints. Italy and Spain continue to strengthen HTS-related work in oncology, neuroscience, infectious disease research, and academic screening networks.

China has rapidly expanded HTS capacity through major investments in biotechnology, pharmaceutical innovation, automation, AI, and large-scale biomedical research. India is advancing through its generics base, contract research capabilities, bioinformatics talent, and expanding discovery-focused biotechnology sector. Japan remains a high-quality HTS environment with strengths in precision instrumentation, cell biology, regenerative medicine, and pharmaceutical innovation. Australia contributes through translational research, immunology, oncology, genomics, and strong university-linked biomedical programs. South Korea is increasingly prominent due to biotechnology investment, digital health capabilities, biologics expertise, and strong integration of laboratory automation with data-driven research.

Actionable Recommendations for High-Throughput Screening Leaders

Industry leaders should prioritize HTS platforms that combine automation flexibility with strong assay biology. Investments should focus on modular robotics, validated liquid handling, high-content imaging, microplate readers, acoustic dispensing, compound management, and integrated informatics that support end-to-end traceability. Organizations should strengthen assay development by using appropriate controls, Z-factor and signal-to-background assessments, replicate strategies, orthogonal confirmation assays, and early counter-screening to reduce false discovery risk.

Leaders should also build AI-ready data foundations. This includes standardized metadata, controlled vocabularies, harmonized image formats, interoperable laboratory systems, and governance practices that enable reproducible machine learning. Cross-functional teams should bring together assay biologists, automation engineers, chemoinformaticians, data scientists, quality specialists, and translational researchers. Strategic partnerships with academic screening centers, contract research providers, and technology developers can accelerate access to specialized platforms while preserving internal expertise. Finally, decision-makers should align HTS investments with priority therapeutic areas, translational validation plans, and compliance expectations to ensure screening outputs generate actionable scientific value.

Research Methodology for High-Throughput Screening Analysis

This executive summary is developed using a secondary research approach grounded in publicly available, verifiable, and industry-relevant sources. The research process considers peer-reviewed scientific literature, regulatory guidance, academic screening center publications, public health and biomedical research reports, patent and technology trend signals, conference proceedings, and recognized standards related to assay validation, laboratory automation, data integrity, and bioinformatics.

The methodology emphasizes triangulation across multiple source categories to identify consistent trends in high-throughput screening applications, technologies, regional adoption patterns, and AI integration. Qualitative analysis is used to assess shifts in automation, high-content screening, phenotypic assays, miniaturization, data management, and translational research workflows. Regional, group, and country insights are synthesized from documented research infrastructure, policy direction, scientific capability, and life science ecosystem maturity. No market sizing, market share, or forecasting assumptions are used in the preparation of this summary.

Conclusion: High-Throughput Screening as a Data-Driven Discovery Engine

High-throughput screening is moving beyond rapid sample testing toward integrated, biology-rich, and data-driven discovery. Automation, miniaturization, high-content imaging, phenotypic assays, and AI-enabled analytics are improving the efficiency and interpretability of screening campaigns across drug discovery, toxicology, genomics, chemical biology, and translational medicine. The strongest opportunities are emerging where robust assay design, interoperable informatics, quality governance, and multidisciplinary expertise converge.

As regional ecosystems mature, HTS will remain central to accelerating early discovery and improving the selection of candidates for downstream validation. Organizations that invest in scalable automation, reproducible assay systems, AI-ready data infrastructure, and collaborative research networks will be better positioned to convert complex biological data into actionable scientific insights while maintaining quality, compliance, and translational relevance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. High-Throughput Screening Market, by Product Type

  • 7.1. Introduction
  • 7.2. Consumables
    • 7.2.1. Labware
    • 7.2.2. Reagents & Assay Kits
  • 7.3. Instruments
    • 7.3.1. Detection Systems
    • 7.3.2. Liquid Handling Systems
  • 7.4. Services
    • 7.4.1. Assay Development & Validation
    • 7.4.2. Screening
  • 7.5. Software
    • 7.5.1. Compound Management
    • 7.5.2. Data Analysis

8. High-Throughput Screening Market, by Technology

  • 8.1. Introduction
  • 8.2. Cell-Based Assays
    • 8.2.1. Fluorometric Imaging Plate Reader Assays
    • 8.2.2. Reporter based Assays
  • 8.3. Lab-on-a-chip Technology (LOC)
  • 8.4. Label-free Technology
  • 8.5. Microfluidics Based

9. High-Throughput Screening Market, by Plate Format

  • 9.1. Introduction
  • 9.2. 1536-well plate
  • 9.3. 384-well plate
  • 9.4. 96-well plate

10. High-Throughput Screening Market, by Application

  • 10.1. Introduction
  • 10.2. Drug Discovery
  • 10.3. Genomics & Proteomics
  • 10.4. Molecular Screening
  • 10.5. Toxicology & Safety Assessment

11. High-Throughput Screening Market, by End User

  • 11.1. Introduction
  • 11.2. Academic & Research Institutes
  • 11.3. Contract Research Organizations
  • 11.4. Hospitals & Diagnostic Labs
  • 11.5. Pharmaceutical & Biotechnology Companies

12. High-Throughput Screening Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. High-Throughput Screening Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. High-Throughput Screening Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. Aurora Biomed, Inc.
  • 16.3. Bio-Rad Laboratories, Inc.
  • 16.4. Biomat S.r.l
  • 16.5. BMG LABTECH GmbH
  • 16.6. BRAND GMBH + CO KG
  • 16.7. Charles River Laboratories International, Inc.
  • 16.8. Corning Incorporated
  • 16.9. Creative Biolabs, Inc.
  • 16.10. Danaher Corporation
  • 16.11. DIANA Biotechnologies, a.s
  • 16.12. Eppendorf SE
  • 16.13. EUROFINS SCIENTIFIC SE
  • 16.14. Gilson Company, Inc.
  • 16.15. Hamilton Company
  • 16.16. HighRes BioSolutions, Inc.
  • 16.17. Lonza Group AG
  • 16.18. Merck KGaA
  • 16.19. Mettler Toledo International, Inc.
  • 16.20. PerkinElmer, Inc.
  • 16.21. Revvity, Inc.
  • 16.22. Sartorius AG
  • 16.23. Tecan Trading AG
  • 16.24. Thermo Fisher Scientific Inc.
  • 16.25. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH-THROUGHPUT SCREENING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HIGH-THROUGHPUT SCREENING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HIGH-THROUGHPUT SCREENING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL HIGH-THROUGHPUT SCREENING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LABWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LABWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LABWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL REAGENTS & ASSAY KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL REAGENTS & ASSAY KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REAGENTS & ASSAY KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DETECTION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DETECTION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DETECTION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIQUID HANDLING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIQUID HANDLING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIQUID HANDLING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ASSAY DEVELOPMENT & VALIDATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ASSAY DEVELOPMENT & VALIDATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ASSAY DEVELOPMENT & VALIDATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COMPOUND MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DATA ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DATA ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DATA ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL-BASED ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CELL-BASED ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL-BASED ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FLUOROMETRIC IMAGING PLATE READER ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FLUOROMETRIC IMAGING PLATE READER ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FLUOROMETRIC IMAGING PLATE READER ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL REPORTER BASED ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REPORTER BASED ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL REPORTER BASED ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LAB-ON-A-CHIP TECHNOLOGY (LOC) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LAB-ON-A-CHIP TECHNOLOGY (LOC) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LAB-ON-A-CHIP TECHNOLOGY (LOC) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LABEL-FREE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LABEL-FREE TECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LABEL-FREE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MICROFLUIDICS BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MICROFLUIDICS BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MICROFLUIDICS BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL 1536-WELL PLATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL 1536-WELL PLATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL 1536-WELL PLATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL 384-WELL PLATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL 384-WELL PLATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL 384-WELL PLATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL 96-WELL PLATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL 96-WELL PLATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL 96-WELL PLATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GENOMICS & PROTEOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GENOMICS & PROTEOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GENOMICS & PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MOLECULAR SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MOLECULAR SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MOLECULAR SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TOXICOLOGY & SAFETY ASSESSMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TOXICOLOGY & SAFETY ASSESSMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL TOXICOLOGY & SAFETY ASSESSMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 177. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 183. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. GCC HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 210. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 213. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 215. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 216. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. G7 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 221. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 223. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 226. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 227. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. NATO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 244. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 245. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 247. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 249. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 250. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. CANADA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 255. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 256. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 257. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 260. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 261. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 262. MEXICO HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 266. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 267. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 269. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 271. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 272. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. BRAZIL HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 288. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 289. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 290. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 291. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 293. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 294. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. GERMANY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 299. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 300. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 301. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 307. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 310. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 311. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 312. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 313. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 314. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 315. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 316. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 317. RUSSIA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 321. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 329. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 332. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 333. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 334. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 335. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 336. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 337. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PLATE FORMAT, 2018-2032 (USD MILLION)
  • TABLE 338. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 339. SPAIN HIGH-THROUGHPUT SCREENING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 341. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 343. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 344. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 345. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 346. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 347. CHINA HIGH-THROUGHPUT SCREENING MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2032 (USD MILLION)
  • TABLE 348. CHINA HIGH-THROUGHPUT SCREENI